ALAB - Astera Labs, Inc. Common Stock
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$277.73
DETAILS
HIGH:
$460.00
LOW:
$153.00
MEDIAN:
$270.00
CONSENSUS:
$277.73
DOWNSIDE:
39.09%
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | 852.5 | 396.3 | 115.8 | 79.9 |
| Cost of Revenue | 207.3 | 93.6 | 36.0 | 21.2 |
| Gross Profit | 645.3 | 302.7 | 79.8 | 58.7 |
| Operating Expenses | ||||
| R&D Expenses | 304.0 | 200.8 | 73.4 | 73.7 |
| SG&A Expenses | 167.8 | 217.9 | 35.9 | 45.2 |
| Other Expenses | 0 | 0 | 0 | 0 |
| Operating Expenses | 471.8 | 418.8 | 109.3 | 118.9 |
| Operating Income | ||||
| Operating Income | 173.4 | (116.1) | (29.5) | (60.2) |
| Interest Expense | 0 | 0 | 0 | 0 |
| Interest Income | 44.7 | 34.3 | 6.5 | 2.6 |
| Profitability | ||||
| EBITDA | 225.0 | (78.6) | (21.2) | (56.8) |
| EBIT | 218.2 | (81.8) | (22.9) | (57.6) |
| Income Before Tax | 218.2 | (81.8) | (22.9) | (57.6) |
| Income Tax Expense | (1.0) | 1.6 | 3.3 | 0.8 |
| Net Income | 219.1 | (83.4) | (26.3) | (58.3) |
| Per Share Data | ||||
| EPS (Basic) | 1.32 | -0.64 | -0.17 | -0.45 |
| EPS (Diluted) | 1.22 | -0.64 | -0.17 | -0.45 |
| Shares Outstanding | 166.4 | 131.3 | 152.5 | 130.5 |
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Current Assets | ||||
| Cash & Cash Equivalents | 167.6 | 79.6 | 45.1 | 76.1 |
| Short-Term Investments | 1,021.2 | 834.8 | 104.2 | 87.1 |
| Net Receivables | 83.2 | 38.8 | 8.3 | 10.7 |
| Inventory | 59.0 | 43.2 | 24.1 | 28.9 |
| Other Current Assets | 31.0 | 16.7 | 0.7 | 0.5 |
| Total Current Assets | 1,362.0 | 1,013.0 | 185.8 | 206.0 |
| Non-Current Assets | ||||
| Property, Plant & Equipment | 92.0 | 35.7 | 7.6 | 3.5 |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 77.8 | 5.9 | 2.9 | 2.2 |
| Total Non-Current Assets | 169.8 | 41.5 | 10.5 | 5.7 |
| Total Assets | 1,531.8 | 1,054.5 | 196.3 | 211.7 |
| Current Liabilities | ||||
| Account Payables | 42.4 | 26.9 | 6.3 | 10.3 |
| Short-Term Debt | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 15 | 0 | 0 |
| Other Current Liabilities | 90.7 | 37.9 | 11.7 | 9.7 |
| Total Current Liabilities | 133.0 | 86.5 | 35.1 | 40.1 |
| Non-Current Liabilities | ||||
| Long-Term Debt | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 3.2 | 3.0 | 256.9 |
| Total Non-Current Liabilities | 35.1 | 3.2 | 3.8 | 256.9 |
| Total Liabilities | 168.2 | 89.7 | 38.9 | 297.0 |
| Stockholders' Equity | ||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | 10.3 | (208.8) | (125.4) | (99.1) |
| Accumulated Other Comprehensive Income | 4.3 | 0.4 | 0.3 | (0.2) |
| Total Stockholders' Equity | 1,363.6 | 964.8 | 157.4 | (85.3) |
| Total Liabilities & Equity | 1,531.8 | 1,054.5 | 196.3 | 211.7 |
| Debt Metrics | ||||
| Total Debt | 35.1 | 1.3 | 2.9 | 1.6 |
| Net Debt | (132.5) | (78.3) | (42.2) | (74.5) |
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | 219.1 | (83.4) | (26.3) | (58.3) |
| Depreciation & Amortization | 6.8 | 3.2 | 1.8 | 0.8 |
| Stock-Based Compensation | 160.0 | 234.6 | 10.7 | 30.2 |
| Change in Working Capital | (66.0) | (13.3) | (9.7) | (10.0) |
| Other Non-Cash Items | (0.7) | (4.3) | 10.8 | 1.4 |
| Operating Cash Flow | 319.3 | 136.7 | (12.7) | (35.9) |
| Investing Activities | ||||
| Capital Expenditure | (37.5) | (34.2) | (2.8) | (3.9) |
| Acquisitions | (28.8) | 0 | 0 | 0 |
| Purchases of Investments | (857.8) | (930.6) | (126.2) | (88.7) |
| Sales/Maturities of Investments | 683.1 | 208.7 | 111.2 | 2.0 |
| Other Investing Activities | (0.5) | (1.4) | 0 | 0 |
| Investing Cash Flow | (241.5) | (757.6) | (17.8) | (90.6) |
| Financing Activities | ||||
| Net Debt Issuance | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | (1.1) | (0.2) | (0.3) |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (15.3) | (0.3) | 2.1 |
| Financing Cash Flow | 9.8 | 655.8 | (0.5) | 151.7 |
| Cash Position | ||||
| Net Change in Cash | 87.6 | 34.9 | (31.0) | 25.2 |
| Cash at Beginning | 80.0 | 45.1 | 76.1 | 50.9 |
| Cash at End | 167.7 | 80.0 | 45.1 | 76.1 |
| Free Cash Flow | 281.8 | 102.4 | (15.5) | (39.8) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 852.5 | 396.3 | 115.8 | 79.9 |
| Gross Profit | 645.3 | 302.7 | 79.8 | 58.7 |
| Operating Income | 173.4 | (116.1) | (29.5) | (60.2) |
| Net Income | 219.1 | (83.4) | (26.3) | (58.3) |
| EPS (Diluted) | 1.22 | -0.64 | -0.17 | -0.45 |
| Balance Sheet | ||||
| Cash & Equivalents | 167.6 | 79.6 | 45.1 | 76.1 |
| Total Assets | 1,531.8 | 1,054.5 | 196.3 | 211.7 |
| Total Debt | 35.1 | 1.3 | 2.9 | 1.6 |
| Stockholders' Equity | 1,363.6 | 964.8 | 157.4 | (85.3) |
| Cash Flow | ||||
| Operating Cash Flow | 319.3 | 136.7 | (12.7) | (35.9) |
| Capital Expenditure | (37.5) | (34.2) | (2.8) | (3.9) |
| Free Cash Flow | 281.8 | 102.4 | (15.5) | (39.8) |